Cargando…
Dynamic epi‐transcriptomic landscape mapping with disease progression in estrogen receptor‐positive breast cancer
Autores principales: | Keelan, Stephen, Ola, Mihaela, Charmsaz, Sara, Cocchiglia, Sinéad, Ottaviani, Daniela, Hickey, Seán, Purcell, Siobhan, Bane, Fiona, Hegarty, Aisling, Doherty, Ben, Sheehan, Katherine, Hudson, Lance, Cosgrove, Nicola, Roux, Benjamin, Laine, Muriel, Greene, Geoffrey, Varešlija, Damir, Hill, Arnold Konrad, Young, Leonie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174082/ https://www.ncbi.nlm.nih.gov/pubmed/36670046 http://dx.doi.org/10.1002/cac2.12407 |
Ejemplares similares
-
Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer
por: Browne, Alacoque L., et al.
Publicado: (2018) -
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype
por: Varešlija, Damir, et al.
Publicado: (2021) -
ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis
por: Charmsaz, Sara, et al.
Publicado: (2020) -
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities
por: Cosgrove, Nicola, et al.
Publicado: (2022) -
S100β as a serum marker in endocrine resistant breast cancer
por: Charmsaz, Sara, et al.
Publicado: (2017)